We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

0IIM Esperion Therapeutics Inc

0.00 (0.00%)
23 Feb 2024 - Closed
Delayed by 15 minutes

Esperion Therapeutics Financial Summary

The current 0IIM market cap is 4.31B. The company's latest EPS is USD -2.0547 and P/E is -1.27.

Year End 31 December 2022 20182019202020212022
Total Revenue 0148.36M227.55M78.45M75.48M
Operating Income -204.59M-93.1M-121.4M-226.73M-179.5M
Net Income -201.81M-97.17M-143.55M-269.11M-233.66M
Year End 31 December 2022 20182019202020212022
Total Assets 143.45M214.45M353.26M381.59M247.94M
Total Liabilities 64.33M194.5M449.39M578.53M571.72M
Total Equity 79.12M19.95M-96.13M-196.94M-323.78M

Cash Flow

Year End 31 December 2022 20182019202020212022
Operating -148.64M-70.34M-85.18M-263.81M-174.83M
Investing 140.45M64.23M21.36M-50.48M8.1M
Financing 10.69M136.2M201.73M268.22M32.61M
Market Cap 4.31B
Price to Earnings Ratio -1.27
Price to Sales Ratio 3.92
Price to Cash Ratio 2.37
Price to Book Ratio -0.91
Dividend Yield -

Share Statistics

Shares Outstanding 113.72M
Average Volume (1 week) 16.94k
Average Volume (1 Month) 12.83k
52 Week Change 0.00%
52 Week High 37.89
52 Week Low 37.89
Spread (Intraday) 0 (0%)

Company Info

Company Name Esperion Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |